Tarsus Pharmaceuticals, Inc. (TARS) Revenue Growth
Tarsus Pharmaceuticals, Inc. (TARS) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2021-12-31 | N/A |
| 2022-12-31 | -54.73% |
| 2023-12-31 | -32.42% |
| 2024-12-31 | 948.62% |
| 2025-12-31 | 146.71% |
How TARS compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| NMTC | NeuroOne Medical Technologies Corporation | 163.47% |
| ETON | Eton Pharmaceuticals Inc. | 104.94% |
| TGTX | TG Therapeutics Inc. | 87.32% |
| TXMD | TherapeuticsMD Inc. | 71.61% |
| AXSM | Axsome Therapeutics Inc. | 65.55% |
These are five companies in the same sector as TARS with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Tarsus Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("TARS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TARS | $71.76 | -0.22% | 0.62M |
| 3 | ||||
| 4 | ||||
| 5 |